These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11792686)

  • 1. Pharmacokinetics and biliary excretion of osaterone acetate, a new steroidal antiandrogen, in dogs.
    Minato K; Koizumi N; Honma S; Tsukamoto K; Iwamura S
    Drug Metab Dispos; 2002 Feb; 30(2):167-72. PubMed ID: 11792686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of osaterone acetate in dogs and humans.
    Minato K; Honma S; Shinohara Y; Hashimoto T
    Steroids; 2005 Aug; 70(9):563-72. PubMed ID: 15923016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterizations of mouse hepatic microsomal monooxygenase catalyzing 11beta-hydroxylation of osaterone acetate.
    Minato K; Koizumi N; Honma S; Iwamura S; Tsukamoto K
    Biochem Pharmacol; 1999 Jul; 58(2):335-41. PubMed ID: 10423176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary and biliary metabolites of 17alpha-acetoxy-6-chloro-4,6-pregnadiene-3,20-dione in the rabbit.
    Abe T; Kambegawa A
    Chem Pharm Bull (Tokyo); 1974 Dec; 22(12):2824-9. PubMed ID: 4143183
    [No Abstract]   [Full Text] [Related]  

  • 5. Regression of prostatic hypertrophy by osaterone acetate in dogs.
    Tsutsu T; Hori T; Shimizu M; Orima H; Kawakami E; Fukuda S
    J Vet Med Sci; 2000 Oct; 62(10):1115-9. PubMed ID: 11073087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The metabolic fate of chlormadinone acetate in the baboon.
    Honjo H; Ishihara M; Osawa Y; Kirdani RY; Sandberg AA
    Steroids; 1976 Jan; 27(1):79-98. PubMed ID: 57656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a new steroidal antiandrogen, TZP-4238 (17 alpha-acetoxy-6-chloro-2-oxa-4, 6-pregnadiene-3, 20-dione), on spontaneously developed canine benign prostatic hyperplasia.
    Takezawa Y; Ito K; Suzuki K; Fukabori Y; Yamanaka H; Honma S; Mieda M; Hamataki N; Kushitani M
    Prostate; 1995 Dec; 27(6):321-8. PubMed ID: 7501544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys.
    Sugimoto T; Hayashi T; Okita A; Morino A
    Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and anti-androgenic activity of the metabolites of 17alpha-acetoxy-6-chloropregna-4,6-diene-3,20-dione (chlormadinone acetate) in the rat, rabbit, dog and man.
    Honma S; Iwamura S; Iizuka K; Kambegawa A; Shida K
    Chem Pharm Bull (Tokyo); 1977 Aug; 25(8):2019-31. PubMed ID: 72616
    [No Abstract]   [Full Text] [Related]  

  • 10. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
    Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
    J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of osaterone acetate on clinical signs and prostate volume in dogs with benign prostatic hyperplasia.
    Socha P; Zduńczyk S; Tobolski D; Janowski T
    Pol J Vet Sci; 2018 Dec; 21(4):559-566. PubMed ID: 30605276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacies of osaterone and delmadinone in the treatment of benign prostatic hyperplasia in dogs.
    Albouy M; Sanquer A; Maynard L; Eun HM
    Vet Rec; 2008 Aug; 163(6):179-83. PubMed ID: 18689779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional, biochemical, and morphological hepatobiliary effects in rats chronically exposed to a steroidal antiandrogen.
    Descotes G; Osman H; Gallas JF; Penacchio E; Moreau C
    Toxicol Appl Pharmacol; 1996 Mar; 137(1):23-33. PubMed ID: 8607138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new synthetic steroid, osaterone acetate (TZP-4238), increases cortical bone mass and strength by enhancing bone formation in ovariectomized rats.
    Fuse H; Fukumoto S; Sone H; Miyata Y; Saito T; Nakayama K; Takahashi H; Matsumoto T; Ogata E
    J Bone Miner Res; 1997 Apr; 12(4):590-7. PubMed ID: 9101370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiandrogen. I. 2-azapregnane and 2-oxapregnane steroids.
    Shibata K; Takegawa S; Koizumi N; Yamakoshi N; Shimazawa E
    Chem Pharm Bull (Tokyo); 1992 Apr; 40(4):935-41. PubMed ID: 1381997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of chlormadinone acetate following single and multiple oral dosing of chlormadinone acetate (2 mg) and ethinylestradiol (0.03 mg) and elimination and clearance of a single dose of radiolabeled chlormadinone acetate.
    Terlinden R; Uragg H; Göhler K; Kneip C
    Contraception; 2006 Sep; 74(3):239-44. PubMed ID: 16904418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiandrogen. II. Oxygenated 2-oxapregnane steroids.
    Takegawa S; Koizumi N; Takahashi H; Shibata K
    Chem Pharm Bull (Tokyo); 1993 May; 41(5):870-5. PubMed ID: 7687931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics, metabolism, and excretion of the glycogen synthase kinase-3 inhibitor LY2090314 in rats, dogs, and humans: a case study in rapid clearance by extensive metabolism with low circulating metabolite exposure.
    Zamek-Gliszczynski MJ; Abraham TL; Alberts JJ; Kulanthaivel P; Jackson KA; Chow KH; McCann DJ; Hu H; Anderson S; Furr NA; Barbuch RJ; Cassidy KC
    Drug Metab Dispos; 2013 Apr; 41(4):714-26. PubMed ID: 23305709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative potency of antiandrogens with reference to intracellular testosterone in the rat prostate.
    Kondo Y; Homma Y; Aso Y; Kawabe K; Mieda M; Takahashi H
    Prostate; 1996 Sep; 29(3):146-52. PubMed ID: 8827082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.